Clinical Trial: Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: Copeptin After Arginine Infusion for the Differential Diagnosis of the Polyuria-Polydipsia Syndrome ''The CARGO-Study''
Brief Summary: the purpose of the study is to investigate whether arginine infusion is a new tool to differentiate patients with diabetes insipidus, primary polydipsia and healthy subjects.
Detailed Summary:
Sponsor: University Hospital, Basel, Switzerland
Current Primary Outcome: Discriminative value of copeptin after arginine infusion in the differential diagnosis of polyuria-polydipsia syndrome. [ Time Frame: up to 120 minutes after the Arginine infusion. ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: University Hospital, Basel, Switzerland
Dates:
Date Received: June 12, 2013
Date Started: June 2013
Date Completion: June 2017
Last Updated: March 13, 2017
Last Verified: March 2017